Catalog Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914); Cardiogenic Shock (2262)
|
Event Date 08/23/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
The bwi product analysis lab received the device for evaluation on 12-sep-2023.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a patient receiving cardiac ablation procedure involving a thermocool® smart touch® sf bi-directional navigation catheter experienced cardiac arrest requiring medical intervention.It was reported that an invalid temperature reading was being displayed on the smartablate generator.The ablation cable was replaced without resolution.The ablation catheter (lot #: 31100155l) was replaced with ablation catheter (lot #: 31095990l) and the issue resolved.The procedure continued.The caller stated that later on during the procedure, after 45 minutes of ablation, the patient's blood pressure dropped.The patient went into "cardiogenic shock from fluid overload".The physician then called the cardiac arrest code.A swan catheter was placed into the patient¿s right side of the heart and wedge pressure measurements were obtained.The physician then placed an impella device into the patient's heart.The caller stated that a bwi ultrasound catheter, a bwi vizigo sheath, a bwi deca nav, and a bwi thermocool® smart touch® sf bi-directional navigation catheter (lot #: 31095990l) were in use when the event occurred.Multiple attempts have been made to obtain clarification to this complaint.However, no further information has been made available.
|
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4) during an internal review, noted a correction to the 3500a follow-up #1.It should have included in the h10.Additional manufacturer narrative: biosense webster manufacturer's reference number (b)(4) has two reports: mfr # 2029046-2023-02334 for product code d134805 (thermocool® smart touch® sf bi-directional navigation catheter ¿ reportable event: malfunction).Mfr # 2029046-2023-02097 for product code d134805 (thermocool® smart touch® sf bi-directional navigation catheter ¿ reportable event: serious injury).
|
|
Manufacturer Narrative
|
It was reported that a patient receiving cardiac ablation procedure involving a thermocool® smart touch® sf bi-directional navigation catheter experienced cardiac arrest requiring medical intervention.The investigation was completed on 19-sep-2023.The product was returned to biosense webster (bwi) for evaluation.A visual inspection and revision of all features were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.In addition, no device malfunction was reported, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|